WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,138 Cr | ₹7,586 Cr | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹8,138 Cr |
| Mar2025 | ₹7,586 Cr |
| Mar2024 | ₹7,070 Cr |
| Mar2023 | ₹7,075 Cr |
| Mar2022 | ₹7,670 Cr |
How is Total Liabilities of WOCKHARDT Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,138 Cr | 7.28 | |
| Mar2025 | ₹7,586 Cr | 7.30 | |
| Mar2024 | ₹7,070 Cr | -0.07 | |
| Mar2023 | ₹7,075 Cr | -7.76 | |
| Mar2022 | ₹7,670 Cr | - | |
Compare Total Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹33,909.7 Cr | 10.8% | 5.8% | 37.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 10.8% |
5.8% |
37.7% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses